Evidence-based management options for women at increased breast/ovarian cancer risk

被引：28

作者：

Pichert, G ^{[1
]}

Bolliger, B ^{[1
]}

Buser, K ^{[1
]}

Pagani, O ^{[1
]}

机构：

[1] Univ Hosp, Dept Med, Div Oncol, Zurich, Switzerland

来源：

ANNALS OF ONCOLOGY | 2003年 / 14卷 / 01期

关键词：

BRCA1; BRCA2; familial risk; hereditary breast cancer; ovarian cancer; prophylactic surgery;

D O I：

10.1093/annonc/mdg030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent developments in our ability to predict breast cancer risk necessitates primary care physicians learn to evaluate breast cancer risk and its importance in shaping decisions concerning surveillance and risk reduction measures. This article reviews the current opinion on risk assessment and management of women with an increased risk of breast/ovarian cancer. Management options are given for women at slightly, moderately and highly elevated breast cancer risk, as well as for BRCA 1/2 carriers, based on currently available evidence.

引用

收藏

页码：9 / 19

页数：11

相关论文

共 103 条

[51] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. [J].

Kauff, ND ;

Satagopan, JM ;

Robson, ME ;

Scheuer, L ;

Hensley, M ;

Hudis, CA ;

Ellis, NA ;

Boyd, J ;

Borgen, PI ;

Barakat, RR ;

Norton, L ;

Offit, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1609-1615

[52] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial [J].

King, MC ;

Wieand, S ;

Hale, K ;

Lee, M ;

Walsh, T ;

Owens, K ;

Tait, J ;

Ford, L ;

Dunn, BK ;

Costantino, J ;

Wickerham, L ;

Wolmark, N ;

Fisher, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18) :2251-2256

[53] Screening women aged less than 50 years with a family history of breast cancer [J].

Kollias, J ;

Sibbering, DM ;

Blamey, RW ;

Holland, PAM ;

Obuszko, Z ;

Wilson, ARM ;

Evans, AJ ;

Ellis, IO ;

Elston, CW .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) :878-883

[54]

KRAMER BS, 1993, CANCER, V71, P589

[55] Hysterectomy, oophorectomy, and heart disease risk factors in older women [J].

KritzSilverstein, D ;

BarrettConnor, E ;

Wingard, DL .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (04) :676-680

[56]

Lakhani SR, 1997, LANCET, V349, P1505

[57] Screening by mammography, women with a family history of breast cancer [J].

Lalloo, F ;

Boggis, CRM ;

Evans, DGR ;

Shenton, A ;

Threlfall, AG ;

Howell, A .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) :937-940

[58]

LevyLahad E, 1997, AM J HUM GENET, V60, P1059

[59] Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer [J].

Li, CI ;

Malone, KE ;

Weiss, NS ;

Daling, JR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (13) :1008-1013

[60] BONE-MINERAL DENSITY IN WOMEN WITH BREAST-CANCER TREATED WITH ADJUVANT TAMOXIFEN FOR AT LEAST 2 YEARS [J].

LOVE, RR ;

MAZESS, RB ;

TORMEY, DC ;

BARDEN, HS ;

NEWCOMB, PA ;

JORDAN, VC .

BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (03) :297-301

← 1 2 3 4 5 6 7 8 9 10 →